Metis Global Partners LLC Trims Stock Position in MetLife, Inc. (NYSE:MET)

Metis Global Partners LLC trimmed its holdings in shares of MetLife, Inc. (NYSE:METFree Report) by 2.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 36,416 shares of the financial services provider’s stock after selling 888 shares during the quarter. Metis Global Partners LLC’s holdings in MetLife were worth $2,982,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of MET. Swedbank AB increased its holdings in MetLife by 5.3% during the third quarter. Swedbank AB now owns 1,970,163 shares of the financial services provider’s stock valued at $162,499,000 after buying an additional 99,328 shares during the period. US Bancorp DE increased its holdings in MetLife by 2.1% during the third quarter. US Bancorp DE now owns 107,634 shares of the financial services provider’s stock valued at $8,878,000 after buying an additional 2,173 shares during the period. Affinity Investment Advisors LLC increased its holdings in MetLife by 23.2% during the third quarter. Affinity Investment Advisors LLC now owns 18,981 shares of the financial services provider’s stock valued at $1,566,000 after buying an additional 3,576 shares during the period. Farther Finance Advisors LLC increased its holdings in MetLife by 19.6% during the third quarter. Farther Finance Advisors LLC now owns 10,840 shares of the financial services provider’s stock valued at $894,000 after buying an additional 1,774 shares during the period. Finally, Chicago Partners Investment Group LLC purchased a new position in MetLife during the third quarter valued at approximately $233,000. 94.99% of the stock is owned by hedge funds and other institutional investors.

MetLife Trading Up 2.5 %

NYSE:MET opened at $86.16 on Friday. MetLife, Inc. has a 12 month low of $67.30 and a 12 month high of $89.05. The firm has a fifty day simple moving average of $83.65 and a 200-day simple moving average of $81.91. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. The company has a market capitalization of $58.69 billion, a P/E ratio of 14.43, a PEG ratio of 0.65 and a beta of 1.07.

MetLife (NYSE:METGet Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. On average, equities research analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be issued a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, February 4th. This represents a $2.18 annualized dividend and a dividend yield of 2.53%. MetLife’s dividend payout ratio (DPR) is presently 36.52%.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on MET. Wells Fargo & Company raised their target price on shares of MetLife from $92.00 to $97.00 and gave the company an “overweight” rating in a research note on Wednesday, February 19th. BMO Capital Markets began coverage on shares of MetLife in a research note on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 target price for the company. JPMorgan Chase & Co. raised their target price on shares of MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. TD Cowen raised their target price on shares of MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research note on Wednesday, November 27th. Finally, StockNews.com downgraded shares of MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Two investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat, MetLife has an average rating of “Moderate Buy” and an average price target of $94.58.

View Our Latest Report on MET

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

See Also

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.